193
Views
0
CrossRef citations to date
0
Altmetric
Research Report

KCTD1 and Scalp-Ear-Nipple (‘Finlay–Marks’) syndrome may be associated with myopia and Thin basement membrane nephropathy through an effect on the collagen IV α3 and α4 chains

, , , , , , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 19-27 | Received 23 Mar 2022, Accepted 03 Nov 2022, Published online: 29 Dec 2022

References

  • Plessis G, Le Truest M, Le Merrer M. Scalp defect, absence of nipples, ear anomalies, renal hypoplasia: another case of Finlay-Marks syndrome. Clin Genet. 1997;52(4):231–34. doi:10.1111/j.1399-0004.1997.tb02553.x.
  • Picard C, Couderc S, Skojaei T, Salomon R, De Lonlay P, Le Merrer M, Munnich A, Lyonnet S, Amiel J. Scalp-ear-nipple (Finlay-Marks) syndrome: a familial case with renal involvement. Clin Genet. 1999;56(2):170–72. doi:10.1034/j.1399-0004.1999.560216.x.
  • Finlay AY, Marks R. An hereditary syndrome of lumpy scalp, odd ears and rudimentary nipples. Br J Dermatol. 1978;99(4):423–30. doi:10.1111/j.1365-2133.1978.tb06182.x.
  • Edwards MJ, McDonald D, Moore P, Rae J. Scalp-ear-nipple syndrome: additional manifestations. Am J Med Genet. 1994;50(3):247–50. doi:10.1002/ajmg.1320500307.
  • Steinberg RD, Ethington J, Esterly NB. Lumpy scalp syndrome. Int J Dermatol. 1990;29(9):657–58. doi:10.1111/j.1365-4362.1990.tb02591.x.
  • Le Merrer M, Renier D, Briard ML. Scalp defect, nipples absence and ears abnormalities: an other case of finlay syndrome. Genet Couns. 1991;2(4):233–36.
  • Eckert D, Buhl S, Weber S, Jager R, Schorle H. The AP-2 family of transcription factors. Genome Biol. 2005;6(13):246. doi:10.1186/gb-2005-6-13-246.
  • Hilger-Eversheim K, Moser M, Schorle H, Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene. 2000;260(1–2):1–12. doi:10.1016/S0378-1119(00)00454-6.
  • Li X, Chen C, Wang F, Huang W, Liang Z, Xiao Y, Wei K, Wan Z, Hu X, Xiang S, et al. KCTD1 suppresses canonical Wnt signaling pathway by enhancing beta-catenin degradation. PLoS One. 2014;9(4):e94343. doi:10.1371/journal.pone.0094343.
  • Ding X, Luo C, Zhou J, Zhong Y, Hu X, Zhou F, Ren K, Gan L, He A, Zhu J, et al. The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation. J Cell Biochem. 2009;106(2):285–95. doi:10.1002/jcb.22002.
  • Milunsky JM, Maher TA, Zhao G, Roberts AE, Stalker HJ, Zori RT, Burch MN, Clemens M, Mulliken JM, Smith R, et al. TFAP2A mutations result in branchio-oculo-facial syndrome. Am J Hum Genet. 2008;82(5):1171–77. doi:10.1016/j.ajhg.2008.03.005.
  • Satoda M, Pierpont ME, Diaz GA, Bornemeier RA, Gelb BD. Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. Circulation. 1999;99(23):3036–42. doi:10.1161/01.CIR.99.23.3036.
  • Char F. Peculiar facies with short philtrum, duck-bill lips, ptosis and low-set ears–a new syndrome? Birth Defects Orig Artic Ser. 1978;14(6B):303–05.
  • Zannolli R, Mostardini R, Matera M, Pucci L, Gelb BD, Morgese G. Char syndrome: an additional family with polythelia, a new finding. Am J Med Genet. 2000;95(3):201–03. doi:10.1002/1096-8628(20001127)95:3<201:AID-AJMG3>3.0.CO;2-W.
  • Slavotinek A, Clayton-Smith J, Super M. Familial patent ductus arteriosus: a further case of CHAR syndrome. Am J Med Genet. 1997;71(2):229–32. doi:10.1002/(SICI)1096-8628(19970808)71:2<229:AID-AJMG22>3.0.CO;2-F.
  • Gestri G, Osborne RJ, Wyatt AW, Gerrelli D, Gribble S, Stewart H, Fryer A, Bunyan DJ, Prescott K, Collin JRO, et al. Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators. Hum Genet. 2009;126(6):791–803. doi:10.1007/s00439-009-0730-x.
  • Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature. 1996;381(6579):235–38. doi:10.1038/381235a0.
  • Sweeney E, Fryer A, Walters M. Char syndrome: a new family and review of the literature emphasising the presence of symphalangism and the variable phenotype. Clin Dysmorphol. 2000;9(3):177–82. doi:10.1097/00019605-200009030-00005.
  • Moser M, Ruschoff J, Buettner R. Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. Dev Dyn. 1997;208(1):115–24. doi:10.1002/(SICI)1097-0177(199701)208:1<115:AID-AJA11>3.0.CO;2-5.
  • Lancaster MA, Gleeson JG. Cystic kidney disease: the role of Wnt signaling. Trends Mol Med. 2010;16(8):349–60. doi:10.1016/j.molmed.2010.05.004.
  • Buzza M, Wilson D, Savige J. Segregation of haeamturia in thin basement membrane disease with haplotypes at the loci for Alport syndrome. Kidney Int. 2001;59(5):1670–76. doi:10.1046/j.1523-1755.2001.0590051670.x.
  • Sevillano AM, Gutierrez E, Morales E, Hernandez E, Molina M, Gonzalez E, Praga M. Multiple kidney cysts in thin basement membrane disease with proteinuria and kidney function impairment. Clin Kidney J. 2014;7:251–56. doi:10.1093/ckj/sfu033.
  • Gulati A, Sevillano AM, Praga M, Gutierrez E, Alba I, Dahl NK, Besse W, Choi J, Somlo S. Collagen IV gene mutations in adults with bilateral renal cysts and CKD. Kidney Int Rep. 2019;5(1):103–08. doi:10.1016/j.ekir.2019.09.004.
  • Shannon MB, Patton B, Harvey SJ, Miner JH. A hypomorphic mutation in the mouse laminin α5 gene causes polycystic kidney disease. J Am Soc Nephrol. 2006;17(7):1913–22. doi:10.1681/ASN.2005121298.
  • Guo H, Tong P, Liu Y, Wang T, Tian Q, Li Y, Zheng Y, Li Y, et al. Mutations of P4HA2 encoding prolyl 4-hydroxylase 2 are associated with non-syndromic high myopia. Genet in Med. 2015;17:300–36.
  • Hudson DM, Joeng KS, Werther R, Rajagopal A, Weis M, Lee BH, Eyre DR. Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations. J Biol Chem. 2015;290(13):8613–22. doi:10.1074/jbc.M114.634915.
  • Marneros AG, Beck AE, Turner EH, McMillin MJ, Field M, Sobreira NL, Perez ABA, Fortes SAR, Lampe AK, et al. Mutations in KCTD1 cause scalp-ear-nipple sydnrome. Am J Hum Genet. 2013;92(4):621–26. doi:10.1016/j.ajhg.2013.03.002.
  • Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, Massouras A. Varsome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978–80. doi:10.1093/bioinformatics/bty897.
  • Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, et al. Standards and guidelines for the interpretation of seqeunce variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet in Med. 2015;17:405–23.
  • Wu H, Malone A, Donnelly E, Kirita Y, Uchimura K, Ramakrishnan SM, Gaut JP, Humphreys BD. Single cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response. J Am Soc Nephrol. 2018;29:2069–80. doi:10.1681/ASN.2018020125.
  • Eppig JT, Smith CL, Blake JA, Ringwald M, Kadin JA, Richardson JE, Bult CJ. Mouse Genome Informatics (MGI):resources for mining mouse genetic, genomic, and biological data in support of primary and translational research. Methods Mol Biol. Syst Genet. 2016:47–73.
  • Flitcroft DI, Loughman J, Wildsoet CF, Williams C, Guggenheim JA. Novel myopia genes and pathways identified from syndromic forms of myopia. Invest Ophthalmol Vis Sci. 2018;59(1):338–48. doi:10.1167/iovs.17-22173.
  • Jin K, Jiang H, Xiao D, Zou M, Zhu J, Xiang M. Tfap2α and 2β act downstream of Ptf1a to promote amacrine cell differentiation during retinogenesis. Mol Brain. 2015;8:28. doi:10.1186/s13041-015-0118-x.
  • Deltour S, Guerardel C, Leprince D. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc Natl Acad Sci U S A. 1999;96(26):14831–36. doi:10.1073/pnas.96.26.14831.
  • Kobayashi A, Yamagiwa H, Hoshino H, Muto A, Sato K, Morita M, Hayashi N, Yamamoto M, Igarashi K. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol Cell Biol. 2000;20(5):1733–46. doi:10.1128/MCB.20.5.1733-1746.2000.
  • Aygun C, Oran O, Caglar M, Tekinalp G, Yurdakok M, Yigit Ş. Cord blood insulin and C-peptide levels: correlations with birthweight. Acta Paediatr. 1998;87(10):1101–02. doi:10.1111/j.1651-2227.1998.tb01426.x.
  • Miner JH. Glomerular basement membrane composition and the filtration barrier. Pediatr Nephrol. 2011;26(9):1413–17. doi:10.1007/s00467-011-1785-1.
  • Marneros AG. Magnesium and Calcium homeostasis depend on KCTD1 function in the distal nephron. Cell Rep. 2021;34:108616. doi:10.1016/j.celrep.2020.108616.
  • Marneros AG. AP-2β/KCTD1 control distal nephron differentiation and protect against renal fibrosis. Dev Cell. 2020;54:348–66. doi:10.1016/j.devcel.2020.05.026.
  • Hood J, Savige J, Hendtlass A, Kleppel MM, Huxtable CR, Robinson WF. Bull terrier hereditary nephritis: a model for autosomal dominant Alport sydnrome. Kidney Int. 1995;47(3):758–65. doi:10.1038/ki.1995.116.
  • Hood J, Dowling J, Bertram JF, Kleppel MM, Huxtable CR, Robinson WF. Correlation of histopathological features and renal impairment in autoosmal dominant Alport syndrome. Neph Dial Transplant. 2002;17(11):1897–908. doi:10.1093/ndt/17.11.1897.
  • Kumar S, Rathkolb B, Sabrautzki S, Krebs S, Kemter E, Becker L, Beckers J, Bekeredjian R, Brommage R, Calzada-Wack J, et al. Standardized, systemic phenotypic analysis reveals kidney dysfunction as main alteration of Kctd1 I27N mutant mice. J Biomed Sci. 2017;24(1):57. doi:10.1186/s12929-017-0365-5.
  • Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodolou S, Hadjiconstantinou V, Athanasiou Y, Patsias C, Alexopoulos E, et al. COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol. 2007;18(11):3004–16. doi:10.1681/ASN.2007040444.
  • Savige J, Ratnaike S, Colville D. Retinal abnormalities characteristic of inherited renal disease. J Am Soc Nephrol. 2011;22(8):1403–15. doi:10.1681/ASN.2010090965.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.